Northwest Bancshares, Inc. Vertex Pharmaceuticals Inc Transaction History

Northwest Bancshares, Inc.

$539 Million
Q4 2024

A detailed history of Northwest Bancshares, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Northwest Bancshares, Inc. holds 11,721 shares of VRTX stock, worth $5.68 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares

11,721

Previous 13,125 10.7%

Holding current value

$5.68 Million

Previous $6.1 Million 22.67%

% of portfolio

0.88%

Previous 1.04%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$396.64 - $516.74 $556,882 - $725,502	-1,404 Reduced 10.7%	11,721 $4.72 Million
Q3 2024 Nov 08, 2024	SELL	$460.0 - $505.78 $1.23 Million - $1.36 Million	-2,683 Reduced 16.97%	13,125 $6.1 Million
Q2 2024 Aug 08, 2024	SELL	$392.81 - $485.53 $222,723 - $275,295	-567 Reduced 3.46%	15,808 $7.41 Million
Q1 2024 Apr 26, 2024	SELL	$407.69 - $446.08 $214,852 - $235,084	-527 Reduced 3.12%	16,375 $6.84 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $61,397 - $73,511	-179 Reduced 1.05%	16,902 $6.88 Million
Q3 2023 Oct 27, 2023	SELL	$338.18 - $362.46 $206,289 - $221,100	-610 Reduced 3.45%	17,081 $5.94 Million
Q2 2023 Jul 24, 2023	SELL	$314.42 - $351.91 $236,758 - $264,988	-753 Reduced 4.08%	17,691 $6.23 Million
Q1 2023 May 10, 2023	BUY	$283.23 - $323.1 $101,113 - $115,346	357 Added 1.97%	18,444 $5.81 Million
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $999,302 - $1.12 Million	-3,497 Reduced 16.2%	18,087 $5.22 Million
Q3 2022 Nov 15, 2022	BUY	$273.83 - $305.53 $13,417 - $14,970	49 Added 0.23%	21,584 $6.25 Million
Q2 2022 Aug 16, 2022	SELL	$234.96 - $292.55 $119,594 - $148,907	-509 Reduced 2.31%	21,535 $6.07 Million
Q1 2022 Apr 29, 2022	SELL	$221.42 - $260.97 $310,209 - $365,618	-1,401 Reduced 5.98%	22,044 $5.75 Million
Q4 2021 Feb 09, 2022	BUY	$177.01 - $223.45 $190,993 - $241,102	1,079 Added 4.82%	23,445 $5.15 Million
Q3 2021 Oct 13, 2021	BUY	$181.39 - $202.99 $177,580 - $198,727	979 Added 4.58%	22,366 $4.06 Million
Q2 2021 Aug 06, 2021	BUY	$187.49 - $221.1 $718,836 - $847,697	3,834 Added 21.84%	21,387 $4.31 Million
Q1 2021 Apr 23, 2021	BUY	$207.02 - $241.31 $3.63 Million - $4.24 Million	17,553 New	17,553 $3.77 Million

Others Institutions Holding VRTX

# of Institutions

1,752

Shares Held

227M

Call Options Held

1.63M

Put Options Held

1.47M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $124B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Bancshares, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Northwest Bancshares, Inc. with notifications on news.

Account

Northwest Bancshares, Inc. Vertex Pharmaceuticals Inc Transaction History